SONNET BIOTHERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Operating Liabilities
SONNET BIOTHERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Operating Liabilities of -$30.08 thousand for the 9-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLiabilities · last filed 2020-08-14
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in operating liabilities for the quarter ending 2020-03-31 was -$433.84K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in operating liabilities for the quarter ending 2019-12-31 was -$444.82K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in operating liabilities for the quarter ending 2019-09-30 was -$407.25K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in operating liabilities for the quarter ending 2019-06-30 was -$477.85K.
- SONNET BIOTHERAPEUTICS HOLDINGS, INC. increase (decrease) in operating liabilities for fiscal 2019 was -$1.79M.
| Period end | Increase (Decrease) in Operating Liabilities 3 month | Increase (Decrease) in Operating Liabilities 6 month | Increase (Decrease) in Operating Liabilities 9 month | Increase (Decrease) in Operating Liabilities 12 month |
|---|---|---|---|---|
| 2020-06-30 | -$30.08K 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | -$433.84K 10-Q · filed 2020-05-18 | -$878.66K derived: sum of 2 quarters · filed 2020-05-18 | -$1.29M derived: sum of 3 quarters · filed 2020-05-18 | -$1.76M derived: sum of 4 quarters · filed 2020-05-18 |
| 2019-12-31 | -$444.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$852.07K derived: sum of 2 quarters · filed 2020-03-19 | -$1.33M derived: sum of 3 quarters · filed 2020-03-19 | -$1.79M 10-K · filed 2020-03-19 |
| 2019-09-30 | -$407.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$885.10K derived: sum of 2 quarters · filed 2019-11-14 | -$1.35M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$477.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$941.13K 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | -$463.28K 10-Q · filed 2020-05-18 |